| Size & multiples | |||
| Market Cap | $19.04B | Enterprise Value | $19.56B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 17.63× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 18.11× | EV/FCF | — |
| FCF Yield | −1.25% | Buyback Yield | 0.00% |
| Owner Earnings (TTM) | -$433.2M | Owner Earnings Yield | −2.27% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.62 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 12.11% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −45.94% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$3.32 · revenue TTM $1.08B · FCF TTM -$237.1M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -1.2% | -7.8% | -34.7%–1.4% | 66 ↑strong |
| Net Margin | -42.4% | -21.2% | -325.3%–7.2% | 43 ↓weak |
| Operating Margin | -44.5% | -34.5% | -552.0%–8.0% | 47 ↓weak |
